The Journal of
Clinical Psychiatry

Movement Disorders

Letter to the Editor July 15, 1998

Acute Dystonia With Olanzapine

Pierre Landry ; Jocelyne Cournoyer

J Clin Psychiatry 1998;59(7):384-384

Article Abstract

Sir: Olanzapine is an atypical antipsychotic recently approved for the treatment of schizophrenia. We wish to report 2 cases in which dystonia was attributed to olanzapine use.

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 86 • 2025 • Number 1

Read the Current Issue

Brief Report

Sex Differences in PTSD among US Military Veterans

Commentary

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Clinical and Practical Psychopharmacology

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Commentary

Evolving Care and Research Priorities in ADHD

Original Research

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Systematic Review

Efficacy and Safety of Memantine for Children and Adults with ADHD

View current Issue

Letter to the Editor

Risperidone-Induced Tardive Dyskinesia in an Autistic Child

December 6, 2018

The majority of reported cases of risperidone-induced tardive dyskinesia occurred within 1 year after starting the neuroleptic. However, sometimes there was no cause-and-effect relationship of risperidone and tardive dyskinesia....

Vasco Kidd

Letter to the Editor

Paliperidone-Induced Meige Syndrome

January 26, 2017

Meige syndrome is a focal oral facial dystonia involving symmetrical blepharospasm and oromandibular dystonia. The typical symptom of the disorder is difficulty keeping the eyelids open. This report highlights...

João Gama Marques

Letter to the Editor

Covert Dyskinesia With Aripiprazole

June 9, 2016

Covert dyskinesia is a masked form of tardive dyskinesia that emerges only after antipsychotic drugs are withdrawn or reduced in dosage. Here, read the case of a 53-year-old man...

Yassir Mahgoub , Ahmad Hameed , Andrew Francis

Acute Dystonia With Olanzapine

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

ELSEWHERE:

FOLLOW US:

Acute Dystonia With Olanzapine

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

Related Articles

Risperidone-Induced Tardive Dyskinesia in an Autistic Child

Paliperidone-Induced Meige Syndrome

Covert Dyskinesia With Aripiprazole

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles